3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
150
Lung Neoplasms
58
Pancreatic Neoplasms
34
Neoplasms
20
Neoplasm Metastasis
15
Breast Neoplasms
15
Adenocarcinoma of Lung
15
Brain Neoplasms
14
Adenocarcinoma, Bronchiolo-Alveolar
13
Glioblastoma
12
Non-Squamous Non-Small Cell Lung Cancer
11
Head and Neck Neoplasms
11
Gliosarcoma
11
Squamous Cell Carcinoma of Head and Neck
10
Carcinoma, Hepatocellular
10
Colorectal Neoplasms
8
Carcinoma, Renal Cell
8
Esophageal Neoplasms
6
Urinary Bladder Neoplasms
5
Gallbladder Neoplasms
5
Colonic Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma, Squamous Cell
5
Adenocarcinoma
5
Rectal Neoplasms
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Kidney Neoplasms
4
Fallopian Tube Neoplasms
4
Interventions
Cyclophosphamide
155
Rituximab
148
Etoposide
84
fludarabine phosphate
73
Peripheral Blood Stem Cell Transplantation
68
Mycophenolic Acid
63
Busulfan
62
Filgrastim
59
Melphalan
58
Tacrolimus
54
Whole-Body Irradiation
51
Cytarabine
46
fludarabine
45
Radiotherapy
43
Methotrexate
41
Granulocyte Colony-Stimulating Factor
41
Cyclosporine
41
Vincristine
35
Antilymphocyte Serum
35
Carmustine
33
Doxorubicin
29
Prednisone
26
Thiotepa
25
Bendamustine Hydrochloride
24
Methylprednisolone
22
Ifosfamide
22
Dexamethasone
22
thymoglobulin
21
sargramostim
20
plerixafor
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, Non-Hodgkin
×
Erlotinib Hydrochloride
×
Clear all
NCT03297606
2026-03-27
CAPTUR
Canadian Cancer Trials Group
Phase 2
Recruiting
720 enrolled